Global Urological Cancer Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Urologic cancers include cancers of the bladder, kidney, prostate and testicles, all relatively common. Prostate cancer, for example, is the most common cancer in American men. One out of every 10 men will develop the disease at some time in his life — most often after age 50.
Based on the Urological Cancer Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Urological Cancer Drugs market covered in Chapter 5:
Pfizer
Sanofi S.A.
Astellas
Celgene Corporation
Johnson & Johnson
Roche Healthcare
Indevus Pharmaceuticals Inc
Abbott Laboratories
Tolmar Inc
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
AstraZeneca
Ferring Pharmaceuticals
Dendreon Corporation
Ipsen
In Chapter 6, on the basis of types, the Urological Cancer Drugs market from 2015 to 2025 is primarily split into:
Xofigo (Radium Ra 223 Dichloride)
Jevtana (Cabazitaxel)
Inlyta (Axitinib)
Votrient (Pazopanib Hydrochloride)
Sutent (Sunitinib Malate)
Zytiga (Abiraterone Acetate)
Xtandi (Enzalutamide)
Opdivo (Nivolumab)
Provenge (Sipuleucel-T)
In Chapter 7, on the basis of applications, the Urological Cancer Drugs market from 2015 to 2025 covers:
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Based on the Urological Cancer Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Urological Cancer Drugs market covered in Chapter 5:
Pfizer
Sanofi S.A.
Astellas
Celgene Corporation
Johnson & Johnson
Roche Healthcare
Indevus Pharmaceuticals Inc
Abbott Laboratories
Tolmar Inc
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
AstraZeneca
Ferring Pharmaceuticals
Dendreon Corporation
Ipsen
In Chapter 6, on the basis of types, the Urological Cancer Drugs market from 2015 to 2025 is primarily split into:
Xofigo (Radium Ra 223 Dichloride)
Jevtana (Cabazitaxel)
Inlyta (Axitinib)
Votrient (Pazopanib Hydrochloride)
Sutent (Sunitinib Malate)
Zytiga (Abiraterone Acetate)
Xtandi (Enzalutamide)
Opdivo (Nivolumab)
Provenge (Sipuleucel-T)
In Chapter 7, on the basis of applications, the Urological Cancer Drugs market from 2015 to 2025 covers:
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MARKET OVERVIEW
1.1 Product Definition and Market Characteristics
1.2 Global Urological Cancer Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Pfizer
5.1.1 Pfizer Company Profile
5.1.2 Pfizer Business Overview
5.1.3 Pfizer Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Pfizer Urological Cancer Drugs Products Introduction
5.2 Sanofi S.A.
5.2.1 Sanofi S.A. Company Profile
5.2.2 Sanofi S.A. Business Overview
5.2.3 Sanofi S.A. Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Sanofi S.A. Urological Cancer Drugs Products Introduction
5.3 Astellas
5.3.1 Astellas Company Profile
5.3.2 Astellas Business Overview
5.3.3 Astellas Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Astellas Urological Cancer Drugs Products Introduction
5.4 Celgene Corporation
5.4.1 Celgene Corporation Company Profile
5.4.2 Celgene Corporation Business Overview
5.4.3 Celgene Corporation Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Celgene Corporation Urological Cancer Drugs Products Introduction
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Company Profile
5.5.2 Johnson & Johnson Business Overview
5.5.3 Johnson & Johnson Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Johnson & Johnson Urological Cancer Drugs Products Introduction
5.6 Roche Healthcare
5.6.1 Roche Healthcare Company Profile
5.6.2 Roche Healthcare Business Overview
5.6.3 Roche Healthcare Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Roche Healthcare Urological Cancer Drugs Products Introduction
5.7 Indevus Pharmaceuticals Inc
5.7.1 Indevus Pharmaceuticals Inc Company Profile
5.7.2 Indevus Pharmaceuticals Inc Business Overview
5.7.3 Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Indevus Pharmaceuticals Inc Urological Cancer Drugs Products Introduction
5.8 Abbott Laboratories
5.8.1 Abbott Laboratories Company Profile
5.8.2 Abbott Laboratories Business Overview
5.8.3 Abbott Laboratories Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Abbott Laboratories Urological Cancer Drugs Products Introduction
5.9 Tolmar Inc
5.9.1 Tolmar Inc Company Profile
5.9.2 Tolmar Inc Business Overview
5.9.3 Tolmar Inc Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Tolmar Inc Urological Cancer Drugs Products Introduction
5.10 Bristol-Myers Squibb
5.10.1 Bristol-Myers Squibb Company Profile
5.10.2 Bristol-Myers Squibb Business Overview
5.10.3 Bristol-Myers Squibb Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Bristol-Myers Squibb Urological Cancer Drugs Products Introduction
5.11 GlaxoSmithKline
5.11.1 GlaxoSmithKline Company Profile
5.11.2 GlaxoSmithKline Business Overview
5.11.3 GlaxoSmithKline Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 GlaxoSmithKline Urological Cancer Drugs Products Introduction
5.12 Novartis
5.12.1 Novartis Company Profile
5.12.2 Novartis Business Overview
5.12.3 Novartis Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Novartis Urological Cancer Drugs Products Introduction
5.13 AstraZeneca
5.13.1 AstraZeneca Company Profile
5.13.2 AstraZeneca Business Overview
5.13.3 AstraZeneca Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 AstraZeneca Urological Cancer Drugs Products Introduction
5.14 Ferring Pharmaceuticals
5.14.1 Ferring Pharmaceuticals Company Profile
5.14.2 Ferring Pharmaceuticals Business Overview
5.14.3 Ferring Pharmaceuticals Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Ferring Pharmaceuticals Urological Cancer Drugs Products Introduction
5.15 Dendreon Corporation
5.15.1 Dendreon Corporation Company Profile
5.15.2 Dendreon Corporation Business Overview
5.15.3 Dendreon Corporation Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Dendreon Corporation Urological Cancer Drugs Products Introduction
5.16 Ipsen
5.16.1 Ipsen Company Profile
5.16.2 Ipsen Business Overview
5.16.3 Ipsen Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Ipsen Urological Cancer Drugs Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Urological Cancer Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Urological Cancer Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Urological Cancer Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Urological Cancer Drugs Price by Types (2015-2020)
6.2 Global Urological Cancer Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Urological Cancer Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Urological Cancer Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Urological Cancer Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Urological Cancer Drugs Sales, Price and Growth Rate of Xofigo (Radium Ra 223 Dichloride)
6.3.2 Global Urological Cancer Drugs Sales, Price and Growth Rate of Jevtana (Cabazitaxel)
6.3.3 Global Urological Cancer Drugs Sales, Price and Growth Rate of Inlyta (Axitinib)
6.3.4 Global Urological Cancer Drugs Sales, Price and Growth Rate of Votrient (Pazopanib Hydrochloride)
6.3.5 Global Urological Cancer Drugs Sales, Price and Growth Rate of Sutent (Sunitinib Malate)
6.3.6 Global Urological Cancer Drugs Sales, Price and Growth Rate of Zytiga (Abiraterone Acetate)
6.3.7 Global Urological Cancer Drugs Sales, Price and Growth Rate of Xtandi (Enzalutamide)
6.3.8 Global Urological Cancer Drugs Sales, Price and Growth Rate of Opdivo (Nivolumab)
6.3.9 Global Urological Cancer Drugs Sales, Price and Growth Rate of Provenge (Sipuleucel-T)
6.4 Global Urological Cancer Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Xofigo (Radium Ra 223 Dichloride) Market Revenue and Sales Forecast (2020-2025)
6.4.2 Jevtana (Cabazitaxel) Market Revenue and Sales Forecast (2020-2025)
6.4.3 Inlyta (Axitinib) Market Revenue and Sales Forecast (2020-2025)
6.4.4 Votrient (Pazopanib Hydrochloride) Market Revenue and Sales Forecast (2020-2025)
6.4.5 Sutent (Sunitinib Malate) Market Revenue and Sales Forecast (2020-2025)
6.4.6 Zytiga (Abiraterone Acetate) Market Revenue and Sales Forecast (2020-2025)
6.4.7 Xtandi (Enzalutamide) Market Revenue and Sales Forecast (2020-2025)
6.4.8 Opdivo (Nivolumab) Market Revenue and Sales Forecast (2020-2025)
6.4.9 Provenge (Sipuleucel-T) Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Urological Cancer Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Urological Cancer Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Urological Cancer Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Urological Cancer Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Urological Cancer Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Urological Cancer Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Urological Cancer Drugs Revenue, Sales and Growth Rate of Prostate Cancer (2015-2020)
7.3.2 Global Urological Cancer Drugs Revenue, Sales and Growth Rate of Bladder Cancer (2015-2020)
7.3.3 Global Urological Cancer Drugs Revenue, Sales and Growth Rate of Kidney Cancer (2015-2020)
7.3.4 Global Urological Cancer Drugs Revenue, Sales and Growth Rate of Testicular Cancer (2015-2020)
7.4 Global Urological Cancer Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Prostate Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.2 Bladder Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.3 Kidney Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.4 Testicular Cancer Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Urological Cancer Drugs Sales by Regions (2015-2020)
8.2 Global Urological Cancer Drugs Market Revenue by Regions (2015-2020)
8.3 Global Urological Cancer Drugs Market Forecast by Regions (2020-2025)
9 NORTH AMERICA UROLOGICAL CANCER DRUGS MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Urological Cancer Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Urological Cancer Drugs Market Analysis by Country
9.6.1 U.S. Urological Cancer Drugs Sales and Growth Rate
9.6.2 Canada Urological Cancer Drugs Sales and Growth Rate
9.6.3 Mexico Urological Cancer Drugs Sales and Growth Rate
10 EUROPE UROLOGICAL CANCER DRUGS MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Urological Cancer Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Urological Cancer Drugs Market Analysis by Country
10.6.1 Germany Urological Cancer Drugs Sales and Growth Rate
10.6.2 United Kingdom Urological Cancer Drugs Sales and Growth Rate
10.6.3 France Urological Cancer Drugs Sales and Growth Rate
10.6.4 Italy Urological Cancer Drugs Sales and Growth Rate
10.6.5 Spain Urological Cancer Drugs Sales and Growth Rate
10.6.6 Russia Urological Cancer Drugs Sales and Growth Rate
11 ASIA-PACIFIC UROLOGICAL CANCER DRUGS MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Urological Cancer Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Urological Cancer Drugs Market Analysis by Country
11.6.1 China Urological Cancer Drugs Sales and Growth Rate
11.6.2 Japan Urological Cancer Drugs Sales and Growth Rate
11.6.3 South Korea Urological Cancer Drugs Sales and Growth Rate
11.6.4 Australia Urological Cancer Drugs Sales and Growth Rate
11.6.5 India Urological Cancer Drugs Sales and Growth Rate
12 SOUTH AMERICA UROLOGICAL CANCER DRUGS MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Urological Cancer Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Urological Cancer Drugs Market Analysis by Country
12.6.1 Brazil Urological Cancer Drugs Sales and Growth Rate
12.6.2 Argentina Urological Cancer Drugs Sales and Growth Rate
12.6.3 Columbia Urological Cancer Drugs Sales and Growth Rate
13 MIDDLE EAST AND AFRICA UROLOGICAL CANCER DRUGS MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Urological Cancer Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Urological Cancer Drugs Market Analysis by Country
13.6.1 UAE Urological Cancer Drugs Sales and Growth Rate
13.6.2 Egypt Urological Cancer Drugs Sales and Growth Rate
13.6.3 South Africa Urological Cancer Drugs Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
1.1 Product Definition and Market Characteristics
1.2 Global Urological Cancer Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Pfizer
5.1.1 Pfizer Company Profile
5.1.2 Pfizer Business Overview
5.1.3 Pfizer Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Pfizer Urological Cancer Drugs Products Introduction
5.2 Sanofi S.A.
5.2.1 Sanofi S.A. Company Profile
5.2.2 Sanofi S.A. Business Overview
5.2.3 Sanofi S.A. Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Sanofi S.A. Urological Cancer Drugs Products Introduction
5.3 Astellas
5.3.1 Astellas Company Profile
5.3.2 Astellas Business Overview
5.3.3 Astellas Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Astellas Urological Cancer Drugs Products Introduction
5.4 Celgene Corporation
5.4.1 Celgene Corporation Company Profile
5.4.2 Celgene Corporation Business Overview
5.4.3 Celgene Corporation Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Celgene Corporation Urological Cancer Drugs Products Introduction
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Company Profile
5.5.2 Johnson & Johnson Business Overview
5.5.3 Johnson & Johnson Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Johnson & Johnson Urological Cancer Drugs Products Introduction
5.6 Roche Healthcare
5.6.1 Roche Healthcare Company Profile
5.6.2 Roche Healthcare Business Overview
5.6.3 Roche Healthcare Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Roche Healthcare Urological Cancer Drugs Products Introduction
5.7 Indevus Pharmaceuticals Inc
5.7.1 Indevus Pharmaceuticals Inc Company Profile
5.7.2 Indevus Pharmaceuticals Inc Business Overview
5.7.3 Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Indevus Pharmaceuticals Inc Urological Cancer Drugs Products Introduction
5.8 Abbott Laboratories
5.8.1 Abbott Laboratories Company Profile
5.8.2 Abbott Laboratories Business Overview
5.8.3 Abbott Laboratories Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Abbott Laboratories Urological Cancer Drugs Products Introduction
5.9 Tolmar Inc
5.9.1 Tolmar Inc Company Profile
5.9.2 Tolmar Inc Business Overview
5.9.3 Tolmar Inc Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Tolmar Inc Urological Cancer Drugs Products Introduction
5.10 Bristol-Myers Squibb
5.10.1 Bristol-Myers Squibb Company Profile
5.10.2 Bristol-Myers Squibb Business Overview
5.10.3 Bristol-Myers Squibb Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Bristol-Myers Squibb Urological Cancer Drugs Products Introduction
5.11 GlaxoSmithKline
5.11.1 GlaxoSmithKline Company Profile
5.11.2 GlaxoSmithKline Business Overview
5.11.3 GlaxoSmithKline Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 GlaxoSmithKline Urological Cancer Drugs Products Introduction
5.12 Novartis
5.12.1 Novartis Company Profile
5.12.2 Novartis Business Overview
5.12.3 Novartis Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Novartis Urological Cancer Drugs Products Introduction
5.13 AstraZeneca
5.13.1 AstraZeneca Company Profile
5.13.2 AstraZeneca Business Overview
5.13.3 AstraZeneca Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 AstraZeneca Urological Cancer Drugs Products Introduction
5.14 Ferring Pharmaceuticals
5.14.1 Ferring Pharmaceuticals Company Profile
5.14.2 Ferring Pharmaceuticals Business Overview
5.14.3 Ferring Pharmaceuticals Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Ferring Pharmaceuticals Urological Cancer Drugs Products Introduction
5.15 Dendreon Corporation
5.15.1 Dendreon Corporation Company Profile
5.15.2 Dendreon Corporation Business Overview
5.15.3 Dendreon Corporation Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Dendreon Corporation Urological Cancer Drugs Products Introduction
5.16 Ipsen
5.16.1 Ipsen Company Profile
5.16.2 Ipsen Business Overview
5.16.3 Ipsen Urological Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Ipsen Urological Cancer Drugs Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Urological Cancer Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Urological Cancer Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Urological Cancer Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Urological Cancer Drugs Price by Types (2015-2020)
6.2 Global Urological Cancer Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Urological Cancer Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Urological Cancer Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Urological Cancer Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Urological Cancer Drugs Sales, Price and Growth Rate of Xofigo (Radium Ra 223 Dichloride)
6.3.2 Global Urological Cancer Drugs Sales, Price and Growth Rate of Jevtana (Cabazitaxel)
6.3.3 Global Urological Cancer Drugs Sales, Price and Growth Rate of Inlyta (Axitinib)
6.3.4 Global Urological Cancer Drugs Sales, Price and Growth Rate of Votrient (Pazopanib Hydrochloride)
6.3.5 Global Urological Cancer Drugs Sales, Price and Growth Rate of Sutent (Sunitinib Malate)
6.3.6 Global Urological Cancer Drugs Sales, Price and Growth Rate of Zytiga (Abiraterone Acetate)
6.3.7 Global Urological Cancer Drugs Sales, Price and Growth Rate of Xtandi (Enzalutamide)
6.3.8 Global Urological Cancer Drugs Sales, Price and Growth Rate of Opdivo (Nivolumab)
6.3.9 Global Urological Cancer Drugs Sales, Price and Growth Rate of Provenge (Sipuleucel-T)
6.4 Global Urological Cancer Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Xofigo (Radium Ra 223 Dichloride) Market Revenue and Sales Forecast (2020-2025)
6.4.2 Jevtana (Cabazitaxel) Market Revenue and Sales Forecast (2020-2025)
6.4.3 Inlyta (Axitinib) Market Revenue and Sales Forecast (2020-2025)
6.4.4 Votrient (Pazopanib Hydrochloride) Market Revenue and Sales Forecast (2020-2025)
6.4.5 Sutent (Sunitinib Malate) Market Revenue and Sales Forecast (2020-2025)
6.4.6 Zytiga (Abiraterone Acetate) Market Revenue and Sales Forecast (2020-2025)
6.4.7 Xtandi (Enzalutamide) Market Revenue and Sales Forecast (2020-2025)
6.4.8 Opdivo (Nivolumab) Market Revenue and Sales Forecast (2020-2025)
6.4.9 Provenge (Sipuleucel-T) Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Urological Cancer Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Urological Cancer Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Urological Cancer Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Urological Cancer Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Urological Cancer Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Urological Cancer Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Urological Cancer Drugs Revenue, Sales and Growth Rate of Prostate Cancer (2015-2020)
7.3.2 Global Urological Cancer Drugs Revenue, Sales and Growth Rate of Bladder Cancer (2015-2020)
7.3.3 Global Urological Cancer Drugs Revenue, Sales and Growth Rate of Kidney Cancer (2015-2020)
7.3.4 Global Urological Cancer Drugs Revenue, Sales and Growth Rate of Testicular Cancer (2015-2020)
7.4 Global Urological Cancer Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Prostate Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.2 Bladder Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.3 Kidney Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.4 Testicular Cancer Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Urological Cancer Drugs Sales by Regions (2015-2020)
8.2 Global Urological Cancer Drugs Market Revenue by Regions (2015-2020)
8.3 Global Urological Cancer Drugs Market Forecast by Regions (2020-2025)
9 NORTH AMERICA UROLOGICAL CANCER DRUGS MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Urological Cancer Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Urological Cancer Drugs Market Analysis by Country
9.6.1 U.S. Urological Cancer Drugs Sales and Growth Rate
9.6.2 Canada Urological Cancer Drugs Sales and Growth Rate
9.6.3 Mexico Urological Cancer Drugs Sales and Growth Rate
10 EUROPE UROLOGICAL CANCER DRUGS MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Urological Cancer Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Urological Cancer Drugs Market Analysis by Country
10.6.1 Germany Urological Cancer Drugs Sales and Growth Rate
10.6.2 United Kingdom Urological Cancer Drugs Sales and Growth Rate
10.6.3 France Urological Cancer Drugs Sales and Growth Rate
10.6.4 Italy Urological Cancer Drugs Sales and Growth Rate
10.6.5 Spain Urological Cancer Drugs Sales and Growth Rate
10.6.6 Russia Urological Cancer Drugs Sales and Growth Rate
11 ASIA-PACIFIC UROLOGICAL CANCER DRUGS MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Urological Cancer Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Urological Cancer Drugs Market Analysis by Country
11.6.1 China Urological Cancer Drugs Sales and Growth Rate
11.6.2 Japan Urological Cancer Drugs Sales and Growth Rate
11.6.3 South Korea Urological Cancer Drugs Sales and Growth Rate
11.6.4 Australia Urological Cancer Drugs Sales and Growth Rate
11.6.5 India Urological Cancer Drugs Sales and Growth Rate
12 SOUTH AMERICA UROLOGICAL CANCER DRUGS MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Urological Cancer Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Urological Cancer Drugs Market Analysis by Country
12.6.1 Brazil Urological Cancer Drugs Sales and Growth Rate
12.6.2 Argentina Urological Cancer Drugs Sales and Growth Rate
12.6.3 Columbia Urological Cancer Drugs Sales and Growth Rate
13 MIDDLE EAST AND AFRICA UROLOGICAL CANCER DRUGS MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Urological Cancer Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Urological Cancer Drugs Market Analysis by Country
13.6.1 UAE Urological Cancer Drugs Sales and Growth Rate
13.6.2 Egypt Urological Cancer Drugs Sales and Growth Rate
13.6.3 South Africa Urological Cancer Drugs Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Product Picture
Figure Global Urological Cancer Drugs Market Size and Growth Rate 2015-2025
Table Urological Cancer Drugs Key Market Segments
Figure Global Urological Cancer Drugs Market Revenue ($) Segment by Type from 2015-2020
Figure Global Urological Cancer Drugs Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Urological Cancer Drugs
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Sanofi S.A. Company Profile
Table Sanofi S.A. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sanofi S.A. Production and Growth Rate
Figure Sanofi S.A. Market Revenue ($) Market Share 2015-2020
Table Astellas Company Profile
Table Astellas Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Astellas Production and Growth Rate
Figure Astellas Market Revenue ($) Market Share 2015-2020
Table Celgene Corporation Company Profile
Table Celgene Corporation Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Celgene Corporation Production and Growth Rate
Figure Celgene Corporation Market Revenue ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Market Revenue ($) Market Share 2015-2020
Table Roche Healthcare Company Profile
Table Roche Healthcare Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Roche Healthcare Production and Growth Rate
Figure Roche Healthcare Market Revenue ($) Market Share 2015-2020
Table Indevus Pharmaceuticals Inc Company Profile
Table Indevus Pharmaceuticals Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Indevus Pharmaceuticals Inc Production and Growth Rate
Figure Indevus Pharmaceuticals Inc Market Revenue ($) Market Share 2015-2020
Table Abbott Laboratories Company Profile
Table Abbott Laboratories Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Abbott Laboratories Production and Growth Rate
Figure Abbott Laboratories Market Revenue ($) Market Share 2015-2020
Table Tolmar Inc Company Profile
Table Tolmar Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Tolmar Inc Production and Growth Rate
Figure Tolmar Inc Market Revenue ($) Market Share 2015-2020
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Market Revenue ($) Market Share 2015-2020
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Market Revenue ($) Market Share 2015-2020
Table Novartis Company Profile
Table Novartis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novartis Production and Growth Rate
Figure Novartis Market Revenue ($) Market Share 2015-2020
Table AstraZeneca Company Profile
Table AstraZeneca Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Market Revenue ($) Market Share 2015-2020
Table Ferring Pharmaceuticals Company Profile
Table Ferring Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Ferring Pharmaceuticals Production and Growth Rate
Figure Ferring Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Dendreon Corporation Company Profile
Table Dendreon Corporation Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Dendreon Corporation Production and Growth Rate
Figure Dendreon Corporation Market Revenue ($) Market Share 2015-2020
Table Ipsen Company Profile
Table Ipsen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Ipsen Production and Growth Rate
Figure Ipsen Market Revenue ($) Market Share 2015-2020
Table Global Urological Cancer Drugs Sales by Types (2015-2020)
Table Global Urological Cancer Drugs Sales Share by Types (2015-2020)
Table Global Urological Cancer Drugs Revenue ($) by Types (2015-2020)
Table Global Urological Cancer Drugs Revenue Share by Types (2015-2020)
Table Global Urological Cancer Drugs Price ($) by Types (2015-2020)
Table Global Urological Cancer Drugs Market Forecast Sales by Types (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Sales Share by Types (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue ($) by Types (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue Share by Types (2020-2025)
Figure Global Xofigo (Radium Ra 223 Dichloride) Sales and Growth Rate (2015-2020)
Figure Global Xofigo (Radium Ra 223 Dichloride) Price (2015-2020)
Figure Global Jevtana (Cabazitaxel) Sales and Growth Rate (2015-2020)
Figure Global Jevtana (Cabazitaxel) Price (2015-2020)
Figure Global Inlyta (Axitinib) Sales and Growth Rate (2015-2020)
Figure Global Inlyta (Axitinib) Price (2015-2020)
Figure Global Votrient (Pazopanib Hydrochloride) Sales and Growth Rate (2015-2020)
Figure Global Votrient (Pazopanib Hydrochloride) Price (2015-2020)
Figure Global Sutent (Sunitinib Malate) Sales and Growth Rate (2015-2020)
Figure Global Sutent (Sunitinib Malate) Price (2015-2020)
Figure Global Zytiga (Abiraterone Acetate) Sales and Growth Rate (2015-2020)
Figure Global Zytiga (Abiraterone Acetate) Price (2015-2020)
Figure Global Xtandi (Enzalutamide) Sales and Growth Rate (2015-2020)
Figure Global Xtandi (Enzalutamide) Price (2015-2020)
Figure Global Opdivo (Nivolumab) Sales and Growth Rate (2015-2020)
Figure Global Opdivo (Nivolumab) Price (2015-2020)
Figure Global Provenge (Sipuleucel-T) Sales and Growth Rate (2015-2020)
Figure Global Provenge (Sipuleucel-T) Price (2015-2020)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Xofigo (Radium Ra 223 Dichloride) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Xofigo (Radium Ra 223 Dichloride) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Jevtana (Cabazitaxel) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Jevtana (Cabazitaxel) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Inlyta (Axitinib) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Inlyta (Axitinib) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Votrient (Pazopanib Hydrochloride) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Votrient (Pazopanib Hydrochloride) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Sutent (Sunitinib Malate) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Sutent (Sunitinib Malate) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Zytiga (Abiraterone Acetate) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Zytiga (Abiraterone Acetate) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Xtandi (Enzalutamide) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Xtandi (Enzalutamide) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Opdivo (Nivolumab) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Opdivo (Nivolumab) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Provenge (Sipuleucel-T) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Provenge (Sipuleucel-T) (2020-2025)
Table Global Urological Cancer Drugs Sales by Applications (2015-2020)
Table Global Urological Cancer Drugs Sales Share by Applications (2015-2020)
Table Global Urological Cancer Drugs Revenue ($) by Applications (2015-2020)
Table Global Urological Cancer Drugs Revenue Share by Applications (2015-2020)
Table Global Urological Cancer Drugs Market Forecast Sales by Applications (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Sales Share by Applications (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Prostate Cancer Sales and Growth Rate (2015-2020)
Figure Global Prostate Cancer Price (2015-2020)
Figure Global Bladder Cancer Sales and Growth Rate (2015-2020)
Figure Global Bladder Cancer Price (2015-2020)
Figure Global Kidney Cancer Sales and Growth Rate (2015-2020)
Figure Global Kidney Cancer Price (2015-2020)
Figure Global Testicular Cancer Sales and Growth Rate (2015-2020)
Figure Global Testicular Cancer Price (2015-2020)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Prostate Cancer (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Prostate Cancer (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Bladder Cancer (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Bladder Cancer (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Kidney Cancer (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Kidney Cancer (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Testicular Cancer (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Testicular Cancer (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate (2015-2020)
Table Global Urological Cancer Drugs Sales by Regions (2015-2020)
Table Global Urological Cancer Drugs Sales Market Share by Regions (2015-2020)
Figure Global Urological Cancer Drugs Sales Market Share by Regions in 2019
Figure Global Urological Cancer Drugs Revenue and Growth Rate (2015-2020)
Table Global Urological Cancer Drugs Revenue by Regions (2015-2020)
Table Global Urological Cancer Drugs Revenue Market Share by Regions (2015-2020)
Figure Global Urological Cancer Drugs Revenue Market Share by Regions in 2019
Table Global Urological Cancer Drugs Market Forecast Sales by Regions (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Sales Share by Regions (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure North America Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
Figure North America Urological Cancer Drugs Market Forecast Sales (2020-2025)
Figure North America Urological Cancer Drugs Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Canada Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Mexico Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
Figure Europe Urological Cancer Drugs Market Forecast Sales (2020-2025)
Figure Europe Urological Cancer Drugs Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure France Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Italy Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Spain Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Russia Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Urological Cancer Drugs Market Forecast Sales (2020-2025)
Figure Asia-Pacific Urological Cancer Drugs Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Japan Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure South Korea Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Australia Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure India Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
Figure South America Urological Cancer Drugs Market Forecast Sales (2020-2025)
Figure South America Urological Cancer Drugs Market Forecast Revenue ($) (2020-2025)
Figure Brazil Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Argentina Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Columbia Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Urological Cancer Drugs Market Forecast Sales (2020-2025)
Figure Middle East and Africa Urological Cancer Drugs Market Forecast Revenue ($) (2020-2025)
Figure UAE Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Egypt Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure South Africa Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Product Picture
Figure Global Urological Cancer Drugs Market Size and Growth Rate 2015-2025
Table Urological Cancer Drugs Key Market Segments
Figure Global Urological Cancer Drugs Market Revenue ($) Segment by Type from 2015-2020
Figure Global Urological Cancer Drugs Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Urological Cancer Drugs
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Sanofi S.A. Company Profile
Table Sanofi S.A. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sanofi S.A. Production and Growth Rate
Figure Sanofi S.A. Market Revenue ($) Market Share 2015-2020
Table Astellas Company Profile
Table Astellas Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Astellas Production and Growth Rate
Figure Astellas Market Revenue ($) Market Share 2015-2020
Table Celgene Corporation Company Profile
Table Celgene Corporation Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Celgene Corporation Production and Growth Rate
Figure Celgene Corporation Market Revenue ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Market Revenue ($) Market Share 2015-2020
Table Roche Healthcare Company Profile
Table Roche Healthcare Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Roche Healthcare Production and Growth Rate
Figure Roche Healthcare Market Revenue ($) Market Share 2015-2020
Table Indevus Pharmaceuticals Inc Company Profile
Table Indevus Pharmaceuticals Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Indevus Pharmaceuticals Inc Production and Growth Rate
Figure Indevus Pharmaceuticals Inc Market Revenue ($) Market Share 2015-2020
Table Abbott Laboratories Company Profile
Table Abbott Laboratories Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Abbott Laboratories Production and Growth Rate
Figure Abbott Laboratories Market Revenue ($) Market Share 2015-2020
Table Tolmar Inc Company Profile
Table Tolmar Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Tolmar Inc Production and Growth Rate
Figure Tolmar Inc Market Revenue ($) Market Share 2015-2020
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Market Revenue ($) Market Share 2015-2020
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Market Revenue ($) Market Share 2015-2020
Table Novartis Company Profile
Table Novartis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novartis Production and Growth Rate
Figure Novartis Market Revenue ($) Market Share 2015-2020
Table AstraZeneca Company Profile
Table AstraZeneca Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Market Revenue ($) Market Share 2015-2020
Table Ferring Pharmaceuticals Company Profile
Table Ferring Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Ferring Pharmaceuticals Production and Growth Rate
Figure Ferring Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Dendreon Corporation Company Profile
Table Dendreon Corporation Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Dendreon Corporation Production and Growth Rate
Figure Dendreon Corporation Market Revenue ($) Market Share 2015-2020
Table Ipsen Company Profile
Table Ipsen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Ipsen Production and Growth Rate
Figure Ipsen Market Revenue ($) Market Share 2015-2020
Table Global Urological Cancer Drugs Sales by Types (2015-2020)
Table Global Urological Cancer Drugs Sales Share by Types (2015-2020)
Table Global Urological Cancer Drugs Revenue ($) by Types (2015-2020)
Table Global Urological Cancer Drugs Revenue Share by Types (2015-2020)
Table Global Urological Cancer Drugs Price ($) by Types (2015-2020)
Table Global Urological Cancer Drugs Market Forecast Sales by Types (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Sales Share by Types (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue ($) by Types (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue Share by Types (2020-2025)
Figure Global Xofigo (Radium Ra 223 Dichloride) Sales and Growth Rate (2015-2020)
Figure Global Xofigo (Radium Ra 223 Dichloride) Price (2015-2020)
Figure Global Jevtana (Cabazitaxel) Sales and Growth Rate (2015-2020)
Figure Global Jevtana (Cabazitaxel) Price (2015-2020)
Figure Global Inlyta (Axitinib) Sales and Growth Rate (2015-2020)
Figure Global Inlyta (Axitinib) Price (2015-2020)
Figure Global Votrient (Pazopanib Hydrochloride) Sales and Growth Rate (2015-2020)
Figure Global Votrient (Pazopanib Hydrochloride) Price (2015-2020)
Figure Global Sutent (Sunitinib Malate) Sales and Growth Rate (2015-2020)
Figure Global Sutent (Sunitinib Malate) Price (2015-2020)
Figure Global Zytiga (Abiraterone Acetate) Sales and Growth Rate (2015-2020)
Figure Global Zytiga (Abiraterone Acetate) Price (2015-2020)
Figure Global Xtandi (Enzalutamide) Sales and Growth Rate (2015-2020)
Figure Global Xtandi (Enzalutamide) Price (2015-2020)
Figure Global Opdivo (Nivolumab) Sales and Growth Rate (2015-2020)
Figure Global Opdivo (Nivolumab) Price (2015-2020)
Figure Global Provenge (Sipuleucel-T) Sales and Growth Rate (2015-2020)
Figure Global Provenge (Sipuleucel-T) Price (2015-2020)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Xofigo (Radium Ra 223 Dichloride) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Xofigo (Radium Ra 223 Dichloride) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Jevtana (Cabazitaxel) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Jevtana (Cabazitaxel) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Inlyta (Axitinib) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Inlyta (Axitinib) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Votrient (Pazopanib Hydrochloride) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Votrient (Pazopanib Hydrochloride) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Sutent (Sunitinib Malate) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Sutent (Sunitinib Malate) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Zytiga (Abiraterone Acetate) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Zytiga (Abiraterone Acetate) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Xtandi (Enzalutamide) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Xtandi (Enzalutamide) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Opdivo (Nivolumab) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Opdivo (Nivolumab) (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Provenge (Sipuleucel-T) (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Provenge (Sipuleucel-T) (2020-2025)
Table Global Urological Cancer Drugs Sales by Applications (2015-2020)
Table Global Urological Cancer Drugs Sales Share by Applications (2015-2020)
Table Global Urological Cancer Drugs Revenue ($) by Applications (2015-2020)
Table Global Urological Cancer Drugs Revenue Share by Applications (2015-2020)
Table Global Urological Cancer Drugs Market Forecast Sales by Applications (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Sales Share by Applications (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Prostate Cancer Sales and Growth Rate (2015-2020)
Figure Global Prostate Cancer Price (2015-2020)
Figure Global Bladder Cancer Sales and Growth Rate (2015-2020)
Figure Global Bladder Cancer Price (2015-2020)
Figure Global Kidney Cancer Sales and Growth Rate (2015-2020)
Figure Global Kidney Cancer Price (2015-2020)
Figure Global Testicular Cancer Sales and Growth Rate (2015-2020)
Figure Global Testicular Cancer Price (2015-2020)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Prostate Cancer (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Prostate Cancer (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Bladder Cancer (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Bladder Cancer (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Kidney Cancer (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Kidney Cancer (2020-2025)
Figure Global Urological Cancer Drugs Market Revenue ($) and Growth Rate Forecast of Testicular Cancer (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate Forecast of Testicular Cancer (2020-2025)
Figure Global Urological Cancer Drugs Sales and Growth Rate (2015-2020)
Table Global Urological Cancer Drugs Sales by Regions (2015-2020)
Table Global Urological Cancer Drugs Sales Market Share by Regions (2015-2020)
Figure Global Urological Cancer Drugs Sales Market Share by Regions in 2019
Figure Global Urological Cancer Drugs Revenue and Growth Rate (2015-2020)
Table Global Urological Cancer Drugs Revenue by Regions (2015-2020)
Table Global Urological Cancer Drugs Revenue Market Share by Regions (2015-2020)
Figure Global Urological Cancer Drugs Revenue Market Share by Regions in 2019
Table Global Urological Cancer Drugs Market Forecast Sales by Regions (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Sales Share by Regions (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Urological Cancer Drugs Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure North America Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
Figure North America Urological Cancer Drugs Market Forecast Sales (2020-2025)
Figure North America Urological Cancer Drugs Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Canada Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Mexico Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
Figure Europe Urological Cancer Drugs Market Forecast Sales (2020-2025)
Figure Europe Urological Cancer Drugs Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure France Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Italy Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Spain Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Russia Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Urological Cancer Drugs Market Forecast Sales (2020-2025)
Figure Asia-Pacific Urological Cancer Drugs Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Japan Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure South Korea Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Australia Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure India Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
Figure South America Urological Cancer Drugs Market Forecast Sales (2020-2025)
Figure South America Urological Cancer Drugs Market Forecast Revenue ($) (2020-2025)
Figure Brazil Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Argentina Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Columbia Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Urological Cancer Drugs Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Urological Cancer Drugs Market Forecast Sales (2020-2025)
Figure Middle East and Africa Urological Cancer Drugs Market Forecast Revenue ($) (2020-2025)
Figure UAE Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure Egypt Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
Figure South Africa Urological Cancer Drugs Market Sales and Growth Rate (2015-2020)
